Bibliography
- PALYFREYMAN MN: Phosphodiesterase type IV inhibi-tors as anti-inflammatory agents. Drugs of the Future (1995) 20:793–804.
- RAEBURN D, UNDERWOOD SL, LEWIS SA et al.: Anti-inflammatory and bronchodilator properties of RP73401, a novel and selective phosphodiesterase type IV inhibitor. Brit. J. Pharmacol. (1994) 113:1423–1431.
- MCGEEHAN GM, BECHERER JD, BAST RC et al: Regula-tion of tumour necrosis factor-a processing by a metal-loproteinase inhibitor. Nature (1994) 370:558–561.
- LEE JC, LAYDON JT, MCDONNELL PC et al: A protein ki-nase involved in the regulation of inflammatory cyto-kine biosynthesis. Nature (1994) 372:739–746.
- BEAVO JA, CONTI M, HEASLIP RJ: Multiple cyclic nucleo-tide phosphodiesterases. MM. Pharmacol. (1994) 46:399–405.
- WILLIAMS RD, FELDMANN M, MAINI RN: Anti-tumor ne-crosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA (1992) 89:9783–9788.
- ASHTON MJ, COOK DC, FENTON G et al: Selective type IV phosphodiesterase inhibitors as antiasthmatic agents. The syntheses and biological activities of 3-cyclopentoxy-4-methoxy-benzamides and analogues. J. Med. Chem. (1994) 37:1696–1703.
- •This paper reveals the potent PDE4 inhibitor, RP73401.
- WARRELLOW GJ: The Design and Synthesis of Novel Triarylethanes as Potent, Selective, Orally Active PDE4 Inhibitors of Asthma. Peptidomimetrics and small mole-cule design. Washington DC, March 6–8 (1996).
- BARNETT MS, CHRISTENSEN SB, ESSAYAN DM et al.: SB207499 a potent and selective phosphodiesterase (PDE) IV inhibitor, suppresses activities of several and inflammatory cells. Amer. J. Resp. Grit. Care. Med. (1994) 149(Suppl):Abstr. A209.
- LOMARDO LJ, BAGLI JF, GOLANKIEWICZ JM et al.: Noveloximecarbamates and oxime-carbamates as potent isozyme-selective inhibitors of PDE4. 205th ACS Natl. Meeting (March 28th to April 2nd, Denver). (1993) MEDI–128.
- LOWE JA, CHENG JB: The PDE4 family of calcium-independent phosphodiesterse enzymes. Drugs of the Future (1992) 17:799–807.
- SCHMEICHEN HH, SCHNEIDER HH, WACHTEL H: Closecorrelation between behavioural response and bind-ing in vivo for inhibitors of the rolipram-sensitive phosphodiesterase. Psychopharmacology (1990) 103:17–20.
- WILSON M, SULLIVAN M, BROWN M, HOUSLAY, MD: Pu-rification, characterisation and analysis of rolipram inhibition of a human type IVa cyclic AMP-specific phosphodiesterase expressed in yeast. Biochem. J. (1994) 304:407–415.